- Home
- PSA vs EW Comparison
PSA vs EW Comparison
Compare PSA & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSA
- EW
- Stock Information
- Founded
- PSA 1972
- EW 1958
- Country
- PSA United States
- EW United States
- Employees
- PSA N/A
- EW N/A
- Industry
- PSA Real Estate Investment Trusts
- EW Industrial Specialties
- Sector
- PSA Real Estate
- EW Health Care
- Exchange
- PSA Nasdaq
- EW Nasdaq
- Market Cap
- PSA 53.5B
- EW 44.6B
- IPO Year
- PSA N/A
- EW 2000
- Fundamental
- Price
- PSA $307.69
- EW $78.20
- Analyst Decision
- PSA Buy
- EW Buy
- Analyst Count
- PSA 11
- EW 20
- Target Price
- PSA $342.91
- EW $80.20
- AVG Volume (30 Days)
- PSA 741.8K
- EW 4.5M
- Earning Date
- PSA 04-30-2025
- EW 07-23-2025
- Dividend Yield
- PSA 3.89%
- EW N/A
- EPS Growth
- PSA N/A
- EW 200.69
- EPS
- PSA 10.08
- EW 7.02
- Revenue
- PSA $4,738,938,000.00
- EW $5,522,300,000.00
- Revenue This Year
- PSA $1.33
- EW $11.68
- Revenue Next Year
- PSA $4.04
- EW $9.50
- P/E Ratio
- PSA $30.60
- EW $32.32
- Revenue Growth
- PSA 2.83
- EW 8.23
- 52 Week Low
- PSA $256.60
- EW $58.93
- 52 Week High
- PSA $369.99
- EW $95.25
- Technical
- Relative Strength Index (RSI)
- PSA 55.79
- EW 63.10
- Support Level
- PSA $292.14
- EW $74.20
- Resistance Level
- PSA $307.77
- EW $78.75
- Average True Range (ATR)
- PSA 5.22
- EW 1.48
- MACD
- PSA -0.14
- EW -0.01
- Stochastic Oscillator
- PSA 71.85
- EW 89.15
About PSA Public Storage
Public Storage is the largest owner of self-storage facilities in the US, with more than 3,300 self-storage facilities in 40 states and approximately 245 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage. The company also has a merchandise business, a third-party property management business, and an insurance business that offers products to cover losses for the goods in self-storage facilities.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.